Approvals/NMPA/Fluticasone Furoate, Umeclidinium Bromide and Vilanterol Trifenatate Powder for Inhalation

Approved

化学药品

Fluticasone Furoate, Umeclidinium Bromide and Vilanterol Trifenatate Powder for Inhalation

Unknown🇨🇳 National Medical Products Administration

Approval Id: 8mdl71MkiZF
Approval Number: 国药准字HJ20260003
Generic Name: 氟替美维吸入粉雾剂
Generic Name En: Fluticasone Furoate, Umeclidinium Bromide and Vilanterol Trifenatate Powder for Inhalation
Drug Type: 化学药品
Dosage Form: 吸入粉雾剂
Strength: 每泡含糠酸氟替卡松200μg、乌美溴铵62.5μg（按C₂₉H₃₄NO₂计）与三苯乙酸维兰特罗25μg（按C₂₄H₃₃Cl₂NO₅计），递送剂量为糠酸氟替卡松184μg、乌美溴铵55μg（按C₂₉H₃₄NO₂计）与三苯乙酸维兰特罗22μg（按C₂₄H₃₃Cl₂NO₅计）。
Reg Date: 2026-01-14
Expired Date: 2031-01-13

Approved

Agency

NMPA

Country

🇨🇳

Approval Date

Jan 14, 2026

Approval ID

8mdl71MkiZF

Type

化学药品